Organization: Health Canada
Year: 2024
Month: August
Request Number: A-2024-000252
Request Summary: The cover letter which accompanied the initial filing of the Abbreviated New Drug Submission (ANDS) for Aripiprazole which was accepted into review in April 2024 and subsequently, included in the list of Generic submissions under review dated 2024-05-23 and the corresponding Sponsor Attestation Checklist for ANDS.
Disposition: Disclosed in part
Number of pages: 14